Code Biotherapeutics Announces Collaboration with Takeda to Use Proprietary 3DNA Genetic Medicine Delivery Platform to Design and Develop Gene Therapies for Rare Diseases Read more
Lilly Announces the Institute for Genetic Medicine and $700 Million investment in Boston Seaport Site Read more
Moderna Initiates Phase 3 Portion of Pivotal Trial for mRNA Respiratory Syncytial Virus (RSV) Vaccine Candidate, Following Independent Safety Review of Interim Data Read more
Actinium Pharmaceuticals, Inc. and AVEO Oncology Enter Research Collaboration Agreement to Develop First-in-Class Actinium-225 ErbB3 Targeting Radiotherapy for Solid Tumors Read more
CEPI, THSTI and Panacea Biotec partner to develop broadly protective Betacoronavirus vaccines Read more
Enhertu significantly improved both progression-free and overall survival in DESTINY-Breast04 trial in patients with HER2-low metastatic breast cancer Read more
BioNTech and Medigene announce global collaboration to advance T cell receptor immunotherapies against cancer Read more